Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.944 EUR | -0.84% | +1.51% | -13.24% |
Apr. 30 | Sweden’s Competition Watchdog Prohibits Oriola's Dose Dispensing Unit Sale | MT |
Apr. 29 | ApotekstjÄNst Sverige Ab cancelled the acquisition of Svensk Dos AB. | CI |
Sales 2024 * | 1.55B 1.69B | Sales 2025 * | 1.59B 1.74B | Capitalization | 177M 193M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | 16M 17.42M | EV / Sales 2024 * | 0.11 x |
Net cash position 2024 * | 5.3M 5.77M | Net cash position 2025 * | 23.36M 25.42M | EV / Sales 2025 * | 0.1 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
10.6
x | Employees | 800 |
Yield 2024 * |
8.4% | Yield 2025 * |
9.1% | Free-Float | 70.11% |
Latest transcript on Oriola Oyj
1 day | -1.68% | ||
1 week | +1.51% | ||
Current month | +5.47% | ||
1 month | -5.03% | ||
3 months | -14.18% | ||
6 months | -10.61% | ||
Current year | -13.24% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 11-12-31 | |
Director of Finance/CFO | 54 | 22-11-30 | |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 22-12-31 | |
Director/Board Member | 55 | 22-12-31 | |
Harri Pärssinen
BRD | Director/Board Member | 61 | 19-01-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - | |
0.00% | 34 M€ | +4.20% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 0.944 | -0.84% | 53 979 |
24-05-27 | 0.952 | +1.93% | 75,897 |
24-05-24 | 0.934 | +0.32% | 85,991 |
24-05-23 | 0.931 | -0.21% | 58,112 |
24-05-22 | 0.933 | +0.32% | 56,720 |
Delayed Quote Nasdaq Helsinki, May 28, 2024 at 06:44 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.24% | 193M | |
+21.11% | 72.89B | |
-4.38% | 23.48B | |
+4.65% | 8.67B | |
+10.16% | 8.51B | |
-22.99% | 7.71B | |
+13.19% | 5.21B | |
+1.58% | 4.23B | |
+1.03% | 3.99B | |
+10.84% | 4.08B |
- Stock Market
- Equities
- OKDBV Stock